Zefr Chao
Hialeah, FLNPI 1508445164
Payments from drug & device makers
$14,210in general payments, 2019–2025
Across 99 payments — averaging $143.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$10K
- Sanofi$836
- UCB, Inc.$634
- AstraZeneca$615
- GSK$520
- AbbVie$403
- plus $1K from 16 others
What the payments were for
- Travel & lodging$9,87670%
- Food & beverage$4,23530%
- Education$991%
General payments by program year
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 8 | $9,942 |
| Sanofi | 8 | $836 |
| UCB, Inc. | 20 | $634 |
| AstraZeneca(2 entities) | 8 | $615 |
| GSK | 7 | $520 |
| AbbVie | 8 | $403 |
| Argenx US, Inc. | 4 | $245 |
| Amgen | 7 | $239 |
| Johnson & Johnson | 8 | $199 |
| Novo Nordisk | 1 | $114 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $88 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
| Alvogen Inc | 2 | $51 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Sobi, Inc | 2 | $46 |
| Novartis | 3 | $41 |
| Astellas Pharma US Inc | 1 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| Invivyd Inc | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 16 | $174 |
| Losartan Potassium | 14 | $112 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.